| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS | Sean D. Mersten, Attorney in Fact for Karthik Kuppusamy | 2025-07-25 | 0001955217 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DGX | Common Stock | Small acquisition under Rule 16a-6 | $4.52K | +27 | +0.25% | $167.50 | 10.7K | Jul 21, 2025 | Direct | F1, F2 |
| holding | DGX | Common Stock | 358 | Jul 21, 2025 | By Trust | ||||||
| holding | DGX | Common Stock | 1.63K | Jul 21, 2025 | 401(k) | F3 |
| Id | Content |
|---|---|
| F1 | Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. |
| F2 | The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. |
| F3 | These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. |